Position in GILD
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,174,816
+$974,841 QoQ
Shares Held
17,214
+99.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#805
of 2,265 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KELLEHER FINANCIAL ADVISORS holds $17,885,890 across 12 Drug Manufacturers - General names. GILD ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
17,508 | $4,405,712 | |
| 2 | JNJ |
Johnson & Johnson
|
12,574 | $3,193,418 | |
| 3 | LLY |
ELI LILLY & Co
|
2,498 | $2,996,175 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
17,214 | $2,174,816 | |
| 5 | AMGN |
Amgen Inc
|
5,256 | $1,903,301 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,663 | $1,627,195 | |
| 7 | PFE |
Pfizer Inc
|
51,109 | $1,230,703 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,625 | $208,872 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,174,816 | 17,214 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,199,975 | 8,610 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,053,845 | 8,586 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $46,398 | 418 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $895,829 | 8,080 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $903,347 | 8,062 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $741,638 | 8,029 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $691,176 | 8,244 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $556,152 | 8,106 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $558,970 | 7,631 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $612,921 | 7,566 | Shares | Sole | 2024-04-25 | |
| 2023-09-30 | $575,239 | 7,676 | Shares | Sole | 2024-04-25 | |
| 2023-06-30 | $618,409 | 8,024 | Shares | Sole | 2024-04-25 | |
| 2023-03-31 | $662,598 | 7,986 | Shares | Sole | 2024-04-25 | |
| 2022-12-31 | $680,962 | 7,932 | Shares | Sole | 2024-04-25 | |
| 2022-09-30 | $487,351 | 7,900 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $386,312 | 6,250 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $365,974 | 6,156 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $425,204 | 5,856 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $674,192 | 9,652 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $329,839 | 4,790 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $308,155 | 4,768 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $271,549 | 4,661 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $293,643 | 4,647 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $356,616 | 4,635 | Shares | Sole | 2021-11-02 | |
| 2020-03-31 | $345,690 | 4,624 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||